UNSPSC 51161531: Arofylline

This classification denotes a phosphodiesterase inhibitor with the molecular formula C14H13ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 87L38AY71R, chemically known as 3-(4-chlorophenyl)-1-propyl-3,7-dihydro-1h-purine-2,6-dione but generally known as arofylline, which bears US NIH Compound Identifier 166553. European Medicines Agency schedules Arofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05566MIG.

UNSPSC 51161531 Arofylline is a Commodity code representing a specific pharmaceutical active ingredient that state and local governments procure through health departments, correctional facilities, and public health agencies for inmate care, community health programs, and emergency medical services. Arofylline is a bronchodilator and respiratory stimulant used primarily in respiratory and pulmonary treatment protocols within correctional and public-health settings. State and local issuing bodies under this code include state departments of corrections, county jail systems, municipal health departments, and state public health agencies responsible for pharmacy procurement and inmate or patient care.

The source provides no recent state and local contract opportunities tagged to UNSPSC 51161531 Arofylline, and therefore no geographic spread, representative solicitations, response dates, or issuing-body activity can be characterized from posted RFP, RFQ, IFB, or ITB notices.